# DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award

Source: https://welltoldgrants.com/grants/ht942524prcrpacccta-dod-peer-reviewed-cancer-advancing-cancer-care-through/  
Official notice: https://www.grants.gov/search-results-detail/354992

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 5 awards worth $24.0 million in total. Applications closed on October 15, 2024.

| Field | Value |
|---|---|
| Opportunity number | HT942524PRCRPACCCTA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | October 15, 2024 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 5 |
| Total funding | $24.0 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The FY24 PRCRP ACCCTA supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of cancer within at least one of the FY24 PRCRP Topic Areas. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of- concept trials (e.g., pilot, first-in-human, phase 0) that evaluate the effects of interventions or inform the design of more advanced trials to large-scale trials to determine efficacy in relevant patient populations. Funding from this award mechanism must support a clinical trial. Key aspects of the PRCRP Award Mechanism: · Clinical Trial Start Date: The proposed clinical trial is expected to begin no later than 12 months after the award date or 18 months after the award date for studies regulated by the Regulatory Agency. · Impact: The proposed intervention(s) to be tested should offer significant potential for advancing to the next stage of clinical study, transition of results to fielded science, or improve the standard of care for at least one of the FY24 PRCRP Topic Areas and address one of the FY24 PRCRP Military Health Focus Areas and one of the FY24 PRCRP Overarching Challenges. The impact of the intervention should include considerations of quality of life and supportive care during the trial. · Supportive preclinical data are required: Inclusion of supportive preclinical data relevant for the clinical trial is required. No proposed preclinical research to support an IND/ IDE application is allowed. The data presented to support the initiation of a clinical trial is required. No animal work is allowed. · Study Population: The application should demonstrate the availability of and access to a suitable patient population that will support a meaningful outcome for the study. The application should include a discussion of how accrual goals will be achieved, as well as the strategy for inclusion of women and minorities in the clinical trial appropriate to the objectives of the study. Studies utilizing human biospecimens or datasets that cannot be linked to a specific individual, gender, ethnicity, or race (typically classified as exempt from IRB review) are exempt from this requirement.

## Questions people ask

### Is HT942524PRCRPACCCTA still open?

No. It closed on October 15, 2024. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award?

Closed October 15, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $24.0 million in total across about 5 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.